Xiaoxiang Zhu

Xiaoxiang Zhu is a Senior Principal Scientist and Group Lead for Process Development at Amgen, a leading biotechnology company. He has held various roles within the organization since joining in 2014, including positions as a Process Development Scientist and Sr. Engineer, focusing on upstream cell culture and downstream purification processes. His current role, which he assumed in July 2023, involves leading a team of scientists and managing drug substance activities, supporting technology transfers, and guiding regulatory activities related to drug development.23

Education and Background

Zhu earned his PhD in Chemical Engineering from the Massachusetts Institute of Technology (MIT) (2011-2014) after completing his studies at the University of Illinois at Urbana-Champaign (2008-2010) and Zhejiang University (2002-2008) where he obtained his bachelor's degree. His academic research focused on modeling drug delivery systems, particularly involving biodegradable materials.123

Professional Experience

• Amgen:

  • Sr. Principal Scientist & Group Lead, Process Development (July 2023 - Present)
  • Principal Scientist & Group Lead, Process Development (September 2022 - July 2023)
  • Sr. Scientist & Group Lead, Process Development (April 2020 - September 2022)
  • Process Development Scientist (February 2019 - April 2020)

• Air Products:

  • Sr. Research Engineer (September 2014 - September 2016)

• MIT:

  • Research Assistant, Dept. of Chemical Engineering (January 2011 - August 2014)

Research Contributions

Zhu has published numerous papers focusing on process development and modeling in pharmaceuticals. His work includes developing predictive models for biopharmaceutical processes and optimizing drug delivery mechanisms through innovative engineering solutions.12

In summary, Xiaoxiang Zhu is a prominent figure in the field of process development within the biopharmaceutical industry, with a strong academic background and extensive experience in leading scientific teams at Amgen.